340B Drug Discount Program: Information about Hospitals That Received an Eligibility Exception as a Result of COVID-19
Link
Additional link
Description
Provides an overview of a provision of the Consolidated Appropriations Act, 2022, that allowed hospitals to request an exception to the disproportionate share hospital (DSH) percentage eligibility requirement if they were unable to meet it due to the COVID-19 pandemic. Explores the exception process and provides information on hospitals that received the exception. Discusses the amount of 340B drug purchases and discounts that excepted hospitals indicated they had in 2020 and 2021; the extent to which excepted hospitals indicated providing discounts on 340B drugs to low-income, uninsured patients; and results of the Health Resources and Services Administration's audits and oversight activities to assess program compliance.
Date
05/2023
Type
Document
Organization
Government Accountability Office
Tagged as
Healthcare business and finance · Hospitals · Legislation and regulations · Medicaid · Pharmacy and prescription drugs · Policy · Reimbursement and payment models · Statistics and data